Pulse Biosciences, Inc.
PLSE · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $350K | $0K | |
| Operating income | −$76.9M | −$56.3M | −36.8% |
| Net income | −$72.8M | −$53.6M | −35.8% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $400K | $100K | +300% |
| Operating income | −$24.3M | −$20.4M | −19.1% |
| Net income | −$23.1M | −$19.4M | −19.1% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Pulse Biosciences's revenue in FY2025?
- $350K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Feb 2026.
- Was Pulse Biosciences profitable in FY2025?
- No: net income was −$72.8M and operating income −$76.9M in FY2025.
- What was Pulse Biosciences's revenue in Q3 2026?
- $400K (+300% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.